No Prescription |
 |
 | ||
|
ROCALTROL Generic Calcitriol |
|
| ||
No Prescription » Prescription Drugs 14 » ROCALTROL Generic Calcitriol Calcitriol is a form of vitamin D that is used to treat and prevent low levels of calcium in the blood of patients whose kidneys or parathyroid glands (glands in the neck that release natural substances to control the amount of calcium in the blood) are not working normally. Low blood levels of calcium may cause bone disease. Calcitriol is in a class of medications called vitamins. It works by helping the body to use more of the calcium found in foods or supplements.Calcitriol comes as a capsule and a solution (liquid) to take by mouth. It usually is taken once a day or once every other day in the morning with or without food. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take calcitriol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Calcitriol is also sometimes used to treat rickets (softening and weakening of bones in children caused by lack of vitamin D) osteomalacia (softening and weakening of bones in adults caused by lack of vitamin D) and familial hypophosphatemia (rickets or osteomalacia caused by decreased ability to break down vitamin D in the body). Calcitriol is also sometimes used to increase the amount of calcium in the blood of premature (born early) babies. Talk to your doctor about the risks of using this medication for your condition. Buy ROCALTROL Generic Calcitriol and other Prescription Drugs 14 products online at Medstore. 549
About ROCALTROL Generic Calcitriol: Product Type: Prescription Drugs 14 ROCALTROL ( Generic Calcitriol ) ROCALTROL (Generic Calcitriol) Generic Calcitriol 0.25mcg Caps 30 (3 x 10) Generic Calcitriol ROCALTROL
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
